According to the results of in vitro experiments, IGF-1 treatment of Caki-2 cells (human ccRCC cell line) upregulates IGFBP3, and cell proliferation driven by IGF-1 is obviously increased by exogenous IGFBP3 18,19. This evidence concerns the gene IGFBP3 and nonpapillary renal cell carcinoma.